Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,600 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $300.44 | 5 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $145.06 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $134.93 | 2 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $130.81 | 1 | $0 (2019) |
| Mallinckrodt LLC | $120.47 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $105.18 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
| The Medicines Company | $93.74 | 1 | $0 (2017) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| Philips Electronics North America Corporation | $79.49 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $36.16 | 2 | Gilead Sciences, Inc. ($24.52) |
| 2021 | $64.92 | 3 | Stryker Corporation ($51.54) |
| 2020 | $203.30 | 9 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $562.54 | 8 | PORTOLA PHARMACEUTICALS, INC. ($130.81) |
| 2018 | $139.88 | 2 | Philips Electronics North America Corporation ($79.49) |
| 2017 | $593.43 | 6 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/17/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.52 | General |
| 12/13/2021 | Stryker Corporation | STRYKER (Device) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: SURGICAL | ||||||
| 11/29/2021 | Stryker Corporation | STRYKER (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: SURGICAL | ||||||
| 04/07/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: Cardiovascular | ||||||
| 10/28/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.84 | General |
| Category: Cardiovascular | ||||||
| 10/05/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/05/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/06/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 11/22/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $107.68 | General |
| Category: Cardiovascular | ||||||
| 05/09/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $105.18 | General |
| Category: ANTIBIOTICS | ||||||
| 02/13/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 09/13/2018 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $60.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $79.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 461 | 473 | $627,347 | $50,036 |
| 2022 | 4 | 422 | 430 | $567,482 | $49,950 |
| 2021 | 4 | 489 | 507 | $658,359 | $62,805 |
| 2020 | 3 | 45 | 45 | $45,947 | $4,739 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 199 | 205 | $326,806 | $25,612 | 7.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 176 | 179 | $191,817 | $15,791 | 8.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 40 | $77,376 | $6,326 | 8.2% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 37 | 38 | $26,676 | $1,957 | 7.3% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 11 | 11 | $4,672 | $349.47 | 7.5% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 194 | 198 | $306,964 | $27,037 | 8.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 131 | 132 | $137,528 | $12,330 | 9.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 44 | 45 | $84,723 | $7,588 | 9.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 53 | 55 | $38,267 | $2,996 | 7.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 245 | 260 | $390,204 | $37,455 | 9.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 148 | 151 | $152,030 | $14,353 | 9.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 45 | 45 | $81,732 | $8,152 | 10.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 51 | 51 | $34,393 | $2,845 | 8.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 16 | 16 | $22,844 | $2,483 | 10.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 17 | 17 | $16,635 | $1,681 | 10.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 12 | 12 | $6,468 | $574.79 | 8.9% |
About Dr. Helen Harris, D.O
Dr. Helen Harris, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760833701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Helen Harris, D.O has received a total of $1,600 in payments from pharmaceutical and medical device companies, with $36.16 received in 2022. These payments were reported across 30 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,600).
As a Medicare-enrolled provider, Harris has provided services to 1,417 Medicare beneficiaries, totaling 1,455 services with total Medicare billing of $167,530. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 06/30/2016
- Last Updated 11/25/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1760833701
Products in Payments
- ELIQUIS (Drug) $348.19
- RELISTOR (Drug) $145.06
- XARELTO (Drug) $134.93
- ANDEXXA (Biological) $130.81
- OFIRMEV (Drug) $120.47
- Orbactiv (Drug) $105.18
- XIFAXAN (Drug) $99.39
- MINOCIN IV (Drug) $93.74
- CROFAB (Drug) $89.32
- IGT_D Peripheral (Device) $79.49
- LOKELMA (Drug) $74.07
- CLEVIPREX (Drug) $60.39
- STRYKER (Device) $51.54
- GIAPREZA (Drug) $43.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117